BRIEF DEFINITIVE REPORT sala, Sweden . Sterile pyrogen-free solutions of acid-citrate-dextrose (ACD) and isotonic saline were from Travenol Laboratories, Lessines, Belgium . "'In C13 (2 mCi in 0 .2 ml sterile pyrogen-free 0 .04 N hydrochloric acid) and 1251 human serum albumin (50 uCi/2 mg albumin/ml sterile pyrogen-free isotonic saline) were from Amersham International, Amersham, UK .
Prostacyclin (PG12) sodium salt was a gift from Dr. S . Moncada, Wellcome Research Laboratories, Beckenham, UK.
Methods. TNF preparations were kindly donated by Dr. J . Tavernier, Biogent, Belgium . Mouse and human recombinant TNF were expressed in Escherichia coli and purified to homogeneity as described previously (10) . Using the L929 cytotoxicity assay the specific activity of mouse and human recombinant TNF preparations was 7 .5 x 107 U/mg protein and 2 .5 x 10 7 U/mg protein, respectively. LPS contamination was 36 ng/mg protein by Limulus assay.
Preparation of "'In-labeled Neutrophils (4) . Rabbit neutrophils (>90% pure) were harvested from 72 ml of citrated blood by a two-layer discontinuous (40/60%) Percoll-plasma gradient after initial red cell sedimentation with hydroxyethyl starch (3% final concentration) . Neutrophils (5 x 101-2 x 10 8 cells) were incubated with "' In C13 (50-200 ACi) chelated to MERC (40 /cg) for 15 min at room temperature. The labeled cells were washed twice and resuspended in autologous citrated plasma .
Neutrophil infiltration and oedema formation in the rabbit back skin were measured as the local accumulation of intravenously (marginal ear vein) injected "'In neutrophils and '251 human serum albumin (5 AC i, mixed with 2 ml of a 2 .5% Evans blue dye solution) (4) .
Test agents were injected intradermally in 0 .1-ml vol, each treatment having six replicates . At the end of the experiment, animals were killed by an overdose of pentobarbitone sodium, the back skin was removed, the injection sites were excised, and were then counted in a gamma counter with automatic spill-over correction (5005 Cobra ; Packard Instrument Co. Inc ., Downers Grove, IL) .
Results were expressed in terms of number of "' In neutrophils by comparing skin sample "' In counts with "' In counts per cell in preparations before intravenous injection . Exudate volumes were expressed as microliters of plasma by dividing skin sample "5I counts b y 1251 counts in 1 Al of plasma (4) .
Intradermal injections were given according to a balanced site pattern and injection order was based on a Latin square design . Results are shown as mean t SEM for the number of rabbits indicated ; one data unit being the mean of six replicates in each rabbit .
For neutrophil depletion studies, animals were injected with nitrogen mustard (1 .75 mg/kg, i .v.) 2 d before experimentation (11) . Higher doses of mouse TNF (up to 4,000 U/site, 3 x 10 -12 mol/site) did not result in any larger responses. In all experiments an established chemoattractant (FMLP, 5 x 10 -11 mol/site) and a neutrophil-independent mediator of oedema formation (Bk, 10 -1°mol/site) were included for reference (11) .
As previously documented for FMLP, oedema formation induced by mouse TNF was completely abolished in animals made neutropenic by previous injection of nitrogen mustard (Fig . 1, right panel) . Responses to Bk were not affected .
Infusion of PG12 (50 ng/kg/min, previously shown to have no effect on systemic blood pressure, reference 12) almost completely suppressed mouse TNF and FMLPinduced neutrophil accumulation and oedema formation. Bk-induced leakage was not altered during PG12 infusion (Fig . 1, middle panel ; Fig. 2, right panel) . In the experiments shown in Fig. 3 , the 30-min flux of albumin and neutrophils was measured in inflammatory lesions of different age (0-6 h) . Mouse TNF (40 U/site, 3 x 10 -14 mol/site) or FMLP (5 x 10 -11 mol/site) were injected intradermally at different time intervals (-360-0 min; Fig. 3, x-axis) . At zero time, 1251 albumin and 111I n neutrophils were injected intravenously. At this time, all intradermal sites were reinjected with PGE2 (3 x 10 -1°mol/site) and plasma leakage and neutrophil emigration were measured over a 30-min period . Fig. 3 shows that FMLP-induced leakage and cell accumulation were maximal in the first 30 min and then gradually declined to very low values by 4-6 h. The biological t1i2 of FMLP (for both leakage and neutrophil emigration) was 50-60 min. Similarly, responses to mouse TNF were maximal in the first 30 min; after 30-60 min mouse TNF was no longer active . Based on a more detailed time course (Fig . 3 inset) the biological t1/2 of mouse TNF for oedema formation and cell accumulation was estimated to be 6-7 min. Identical results were obtained with human recombinant TNF. The 30-min flux of albumin and neutrophils in inflammatory lesions of different age (0-6 h) . Mouse TNF (3 x 10 -4 mol/site) or FMLP (5 x 10" mol/site) were injected intradermally at different times (0-360 min, x-axis) before intravenous injection of "5I albumin and I I I In neutrophils (zero time). At this moment all intradermal sites were reinjected with PGE2 (3 x 10 -IO mol/site) and the reaction was allowed to proceed for 30 min. Animals were killed then by an overdose of pentobarbitone sodium and further processed as described in Materials and Methods. For saline-treated sites, the dotted line shows the background for plasma leakage, and the dashed line shows neutrophil accumulation . Results are the mean ± SEM for six rabbits. Discussion TNF is a macrophage-derived peptide that was originally described as the mediator of spontaneous regression of certain tumor cells, discovered in the serum of endotoxin-treated animals (reviewed in references 8, 9, 13). However, several lines of evidence indicate that besides cytostatic and cytotoxic activities, TNF may be an important mediator of inflammation by increasing neutrophil-endothelial cell adherence (6, 7) . The data presented here provide evidence that TNF (already in very low amounts) has potent pro-inflammatory properties in vivo. Under conditions where local blood flow was optimally enhanced by the simultaneous intradermal injection of a vasodilator substance (PGE2), both mouse and human TNF induced neutrophil accumulation and neutrophil-dependent oedema formation in rabbit skin . Comparable dose-response curves for oedema formation and neutrophil emigration were obtained with 0.4-40 U/site of both mouse and human TNF. In view of the three-fold higher specific activity of mouse TNF (7.5 x 107 U/mg vs. 2.5 x 107 U/mg for human TNF), this means that on a molar base, mouse TNF is more effective than human TNF. Therefore, it is possible that TNF receptors on rabbit cells bind mouse TNF with higher affinity than human TNF.
The fast onset and the short duration of action of TNF in rabbit skin (especially the absence of responses after 4-6 h) make it highly unlikely that TNFinduced neutrophil accumulation involves protein biosynthesis-dependent mechanisms, as reported for IL-1 (4, 5). The immediate onset of TNFinduced neutrophil emigration, paralleled by an increase in microvascular permeability, more resembles the pro-inflammatory profile of chemoattractants (C5a, FMLP, LTB4) that are believed to act through activation ofneutrophils (4, 11) . This is further supported by following findings: (a) TNFinduced oedema formation was abolished by neutrophil depletion. (b) TNF induced oedema formation and cell accumulation were greatly suppressed by infu-sion of PGI2 . We have previously provided evidence that in this model PGI2 selectively inhibits neutrophil-dependent responses (12) . (c) In vitro, TNF increased the expression of the CDllb/CD18 glycoproteins, known to be important for neutrophilendothelial cell adherence (results not shown) . Activation of neutrophills by TNF is consistent with a recent report from Rothstein and Schreiber (14) , that TNRinduced hemorrhagic necrosis is critically dependent on circulating neutrophils.
It has also been suggested that activation of neutrophils by TNF may require the production of secondary mediators, such as LTB4 and platelet-activating factor (PAF). It is unlikely, however, that LTB4 or PAF are mediating the inflammatory effects of TNF in this model. The duration of action of LTB4 in rabbit skin is much longer than that of TNF (t112 30 min vs . 6-7 min; Rampart and Williams, unpublished observations); and PAF is a weak chemoattractant in rabbit skin, and PAR induced oedema formation is independent of neutrophils (15) .
The short duration of action of TNF in vivo may be related to its rapid internalization and degradation after binding to its receptor (16) . This short biological halflife of TNF in vivo may be compensated for by the high amounts of TNF that can be produced by macrophages (up to 2% of their protein biosynthesis). However, intradermal injection of much higher amounts of TNF (up to 3 x 10 -12 mol/site) or repeated administration of TNF to the same skin site did not produce larger responses, suggesting that desensitization to TNF may occur very rapidly in vivo (unpublished observations) .
Finally, intravenous administration of TNF to animals is associated with systemic activation of neutrophils, and intratumoral injection of TNF results in massive neutrophil infiltration in the tumor (8, 9, 13) . To what extent neutrophils are involved in the elimination of tumor cells by TNF in vivo is unknown at the present time. There is a large body of in vitro evidence that TNF is directly cytotoxic for many tumor cell lines, thus, independent of neutrophils (13) . Our present data indicate that activation of neutrophils by TNF can be prevented by an infusion of PG12 . It is tempting to speculate that a combination of antitumor treatment with TNF with an infusion of PGI2 may suppress some of the undesired side effects of THE Studies are currently being undertaken to evaluate this hypothesis .
Summary
We have investigated the ability of recombinant TNF (mouse and human) to produce acute inflammatory lesions in an established experimental model of inflammation . Upon intradermal injection in rabbit skin, TNF, in amounts as low as 3 x
